These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 25922143)
1. Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades. Fischer J; Hellmich G; Jackisch T; Puffer E; Zimmer J; Bleyl D; Kittner T; Witzigmann H; Stelzner S Int J Colorectal Dis; 2015 Jun; 30(6):797-806. PubMed ID: 25922143 [TBL] [Abstract][Full Text] [Related]
2. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study. Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270 [TBL] [Abstract][Full Text] [Related]
3. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer. Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Taal BG; Van Tinteren H; Zoetmulder FA; Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425 [TBL] [Abstract][Full Text] [Related]
5. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma. Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465 [TBL] [Abstract][Full Text] [Related]
6. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy]. Thomschke D; Kyau-Ummen B; Halbfass HJ Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499 [TBL] [Abstract][Full Text] [Related]
7. Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study. Lykke J; Jess P; Roikjaer O; Dis Colon Rectum; 2015 Sep; 58(9):823-30. PubMed ID: 26252843 [TBL] [Abstract][Full Text] [Related]
9. Improvements in 5-year outcomes of stage II/III rectal cancer relative to colon cancer. Renouf DJ; Woods R; Speers C; Hay J; Phang PT; Fitzgerald C; Kennecke H Am J Clin Oncol; 2013 Dec; 36(6):558-64. PubMed ID: 22868238 [TBL] [Abstract][Full Text] [Related]
10. Resection of pulmonary metastases from colon and rectal cancer: factors to predict survival differ regarding to the origin of the primary tumor. Meimarakis G; Spelsberg F; Angele M; Preissler G; Fertmann J; Crispin A; Reu S; Kalaitzis N; Stemmler M; Giessen C; Heinemann V; Stintzing S; Hatz R; Winter H Ann Surg Oncol; 2014 Aug; 21(8):2563-72. PubMed ID: 24668147 [TBL] [Abstract][Full Text] [Related]
11. Laparoscopic surgery for colon and rectal cancer. Bärlehner E; Benhidjeb T; Anders S; Schicke B Surg Technol Int; 2004; 13():93-9. PubMed ID: 15744680 [TBL] [Abstract][Full Text] [Related]
12. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y; Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948 [TBL] [Abstract][Full Text] [Related]
13. National Early Rectal Cancer Treatment Revisited. Stornes T; Wibe A; Nesbakken A; Myklebust TÅ; Endreseth BH Dis Colon Rectum; 2016 Jul; 59(7):623-9. PubMed ID: 27270514 [TBL] [Abstract][Full Text] [Related]
14. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. Madbouly KM; Abbas KS; Hussein AM Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666 [TBL] [Abstract][Full Text] [Related]
15. [The role of lymphadenectomy in the surgical treatment of cancer of the left colon and rectum]. Briccoli A; Beghi M; Farinetti A; Guernelli N Minerva Chir; 1990 Feb; 45(3-4):141-3. PubMed ID: 2356026 [TBL] [Abstract][Full Text] [Related]
16. Influence of pT3 subgroups on outcome of R0-resected colorectal tumors. Mrak K; Jagoditsch M; Leibl S; Klingler A; Tschmelitsch J South Med J; 2011 Nov; 104(11):722-30. PubMed ID: 22024778 [TBL] [Abstract][Full Text] [Related]
17. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results]. Kneist W; Heintz A; Wolf HK; Junginger T Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030 [TBL] [Abstract][Full Text] [Related]
18. Variation in colorectal cancer treatment and survival: a cohort study covering the East Anglia region. Warwick J; Will O; Allgood P; Miller R; Duffy S; Greenberg D Colorectal Dis; 2013; 15(10):1243-52. PubMed ID: 23710604 [TBL] [Abstract][Full Text] [Related]
19. Improved survival of colorectal cancer in Denmark during 2001-2012 - The efforts of several national initiatives. Iversen LH; Green A; Ingeholm P; Østerlind K; Gögenur I Acta Oncol; 2016 Jun; 55 Suppl 2():10-23. PubMed ID: 26859340 [TBL] [Abstract][Full Text] [Related]
20. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer. Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]